2. Share Prices
3. VRP.L Share Price
4. VRP.L Share News
5. UK Earnings, Trading Statements Calendar - Next 7 Days

VRP.L Share News (VRP)

• VRP Share
  Price
• VRP Share
  News0
• VRP Share
  Chat0
• VRP Share
  Trades0
• VRP
  Live RNS0
• VRP Share
  Charts
• VRP Broker
  Ratings0
• VRP Directors
  Deals0
• VRP Financial
  Diary
• VRP
  Fundamentals
• VRP Short
  Positions0
• VRP
  Media0

• VRP News
• VRP Professional News

UK Earnings, Trading Statements Calendar - Next 7 Days

Thu, 22nd Oct 2020 16:01

Friday 23 October
Essentra PLC	Third Quarter Results
Barclays PLC	Third Quarter Results
London Stock Exchange Group PLC	Third Quarter Results
InterContinental Hotels Group PLC	Third Quarter Results
Airtel Africa PLC	Half Year Results
Avation PLC	Full Year Results
Monday 26 October
THG Holdings PLC	Third Quarter Results
Tuesday 27 October
Bloomsbury Publishing PLC	Half Year Results
Plus500 Ltd	Third Quarter Results
St James's Place PLC	Third Quarter Results
HSBC Holdings PLC	Third Quarter Results (at 0400 GMT)
Dechra Pharmaceuticals PLC	Trading Statement
Whitbread PLC	Half Year Results
Shoe Zone PLC	Trading Statement
BP PLC	Third Quarter Results
Hunting PLC	Trading Statement
First Derivatives PLC	Half Year Results
Renalytix AI PLC	Full Year Results
ContourGlobal Group PLC	Trading Statement
Wednesday 28 October
John Laing Group PLC	Trading Statement
Ibstock PLC	Trading Statement
Gem Diamonds Ltd	Trading Statement
Elementis PLC	Trading Statement
International Biotechnology Trust PLC	Full Year Results
GlaxoSmithKline PLC	Third Quarter Results (at midday)
Next PLC	Trading Statement
Bank of Ireland Group PLC	Trading Statement
Omega Diagnostics Group PLC	Trading Statement
Itaconix PLC	Half Year Results
Thursday 29 October
Royal Dutch Shell PLC	Third Quarter Results
Angle PLC	Half Year Results
Standard Chartered PLC	Third Quarter Results (at 0415 GMT)
WPP PLC	Trading Statement
Helios Towers PLC	Third Quarter Results
Smith & Nephew PLC	Trading Statement
Lloyds Banking Group PLC	Third Quarter Results
Travis Perkins PLC	Trading Statement
KAZ Minerals PLC	Third Quarter Production
BT Group PLC	Half Year Results
International Personal Finance PLC	Trading Statement
Indivior PLC	Third Quarter Results
Glanbia plc	Third Quarter Results
Foxtons Group PLC	Trading Statement
Evraz PLC	Trading Statement
Smith & Nephew PLC	Third Quarter Trading Statement
Proactis Holdings PLC	Full Year Results
Hilton Food Group PLC	Trading Statement
Verona Pharma PLC	Third Quarter Results
Copyright 2020 Alliance News Limited. All Rights Reserved.

7 Mar 2019 11:28

DIRECTOR DEALINGS: Verona Pharma Chair David Ebsworth Buys Shares

LONDON (Alliance News) - Clinical-stage biopharmaceutical company Verona Pharma PLC said on Thursday Chair David Ebsworth bought 26,300 shares for 56.30 pence each on Wednesday.Following in

Read more

4 Mar 2019 13:35

Monday broker round-up

(Sharecast News) - RSA Insurance Group: JP Morgan downgrades to neutral with a target price of 610p.

Read more

4 Mar 2019 10:12

Verona Pharma Reports Positive Data From Lung Disease Treatment Trial

LONDON (Alliance News) - Shares in Verona Pharma PLC rose on Monday following positive data from part of a Phase Two clinical trial of a dry powder inhaler formulation of Verona's ensifentrine

Read more

14 Jan 2019 10:23

WINNERS & LOSERS SUMMARY: JD Sports Rises After Strong Christmas

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - LOSERS----------Paddy Power

Read more

14 Jan 2019 09:47

Verona Pharma's Ensifentrine COPD Study Does Not Meet Primary Endpoint

LONDON (Alliance News) - Verona Pharma PLC on Monday said its phase two clinical trial of nebulized Ensifentrine did not meet its primary endpoint but did perform better than placebo.Shares

Read more

14 Jan 2019 08:48

Verona Pharma shares plunge on latest drug trial results

(Sharecast News) - Verona Pharma shares were well into the red on Monday, after the clinical-stage biopharmaceutical company announced top-line data from its latest trial of RPL554, failing to reach its primary endpoint.

Read more

9 Jan 2019 15:44

Verona Pharma granted WHO approval for Ensifentrine name

(Sharecast News) - Clinical stage biopharmaceutical outfit Verona Pharma has been granted approval of the name Ensifentrine for its first-in-class, inhaled, dual inhibitor drug candidate RPL554 by the World Health Organisation.

Read more

17 Dec 2018 14:22

Verona Pharma initiates Phase 2 study of RPL554

(Sharecast News) - Clinical-stage biopharmaceutical company Verona Pharma announced the initiation of a Phase 2 clinical trial to evaluate the pharmacokinetic (PK) profile, efficacy and safety of a dry powder inhaler (DPI) formulation of 'RPL554', in patients with moderate to severe chronic obstructive pulmonary disease (COPD), on Monday.

Read more

6 Nov 2018 11:56

Verona Pharma Third-Quarter Loss Narrows On Finance Income

LONDON (Alliance News) - Verona Pharma PLC on Tuesday said its loss narrowed by two thirds in the third quarter of 2018 on increased finance income and reduced costs as it initiated a phase two of

Read more

31 Oct 2018 12:25

Verona Pharma Completes Enrollment In Clinical Trial Of RPL554

LONDON (Alliance News) - Verona Pharma PLC said Wednesday it has completed the enrollment for its Phase 2 clinical trial evaluating the effect of nebulised RPL554 as an add-on to dual therapy in a

Read more

26 Oct 2018 11:46

Verona Pharma turns in positive data from RPL554 trials

(Sharecast News) - Clinical-stage biopharmaceutical company Verona Pharma turned in some positive data from its pre-clinical and Phase 2a trials on its potential cystic fibrosis treatment RPL554.

Read more

1 Aug 2018 12:49

Verona Pharma Starts Phase 2 Trial For Respiratory Disease Treatment

LONDON (Alliance News) - Verona Pharma PLC said Wednesday that it started the second phase of a clinical trial of its nebulized RPL554 drug for the treatment of patients with chronic obstructive 2

Read more

8 May 2018 07:01

LONDON MARKET EARLY CALL: Stocks Called Lower As Iran Fears Boost Oil

LONDON (Alliance News) - Stock prices in London are seen opening lower on Tuesday following Monday's UK bank holiday as Chinese exports recovered at a faster pace in April amid concerns the US

Read more

26 Mar 2018 10:19

Verona Pharma Shares Rise As It Gets Good Results From RPL554 Trials

LONDON (Alliance News) - Verona Pharma PLC said Monday it has received positive top-line data from its phase 2b study for its proposed RPL554 treatment.RPL554 is a for

Read more

8 Mar 2018 13:59

DIRECTOR DEALINGS: Verona Pharma CEO Karlsson Buys 3,250 Shares

LONDON (Alliance News) - Verona Pharma PLC, a clinical-stage biopharmaceutical company, said Thursday that Chief Executive Officer Jan-Anders Karlsson purchased 3,250 ordinary

Read more